Activist 13D/13G Filings - NABRIVA THERAPEUTICS PLC (NBRVF)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-09
09:22 am
Purchase
13GNABRIVA THERAPEUTICS PLC
NBRVF
FMR LLC2,215,958
3.847%
786,699increase
(+55.04%)
View
2021-11-19
12:57 pm
Purchase
13GNABRIVA THERAPEUTICS PLC
NBRVF
Lincoln Park Capital Fund LLC4,512,589
7.96%
4,512,589increase
(New Position)
View
2021-02-08
10:35 am
Purchase
13GNABRIVA THERAPEUTICS PLC
NBRVF
FMR LLC1,429,259
6.78%
1,429,259increase
(New Position)
View
2020-02-12
4:32 pm
Purchase
13GNABRIVA THERAPEUTICS PLC
NBRVF
Longitude Capital Partners II LLC4,256,527
4.5%
244,152increase
(+6.08%)
View
2020-02-07
11:26 am
Purchase
13GNABRIVA THERAPEUTICS PLC
NBRVF
FMR LLC6,131,900
6.485%
6,131,900increase
(New Position)
View
2019-12-26
4:01 pm
Unchanged
13DNABRIVA THERAPEUTICS PLC
NBRVF
ORBIMED ADVISORS LLC4,644,600
4.9%
0
(Unchanged)
View
2019-12-06
4:46 pm
Unchanged
13DNABRIVA THERAPEUTICS PLC
NBRVF
ORBIMED ADVISORS LLC4,644,600
5.9%
0
(Unchanged)
View
2019-08-14
4:31 pm
Sale
13GNABRIVA THERAPEUTICS PLC
NBRVF
Vivo Capital VIII LLC3,528,566
4.8%
-1,272,767decrease
(-26.51%)
View